

Medical tourism in the field of cellular therapy has been increasing exponentially, especially in the past decade, due to multiple advances in the field. Our Viewpoint explores this growing field, with a specific focus on haematopoietic stem-cell transplantation (HSCT) and chimeric antigen receptor (CAR) T-cell therapy. We discuss the global status, regulatory challenges, and ethical considerations associated with medical tourism. We highlight benefits and drawbacks of medical tourism with regard to patient care and the impact on local health-care systems.
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet